Polaris Group (TPE:6550)
Taiwan · Delayed Price · Currency is TWD 30.65
-0.35 (-1.13%)
Feb 2, 2026, 1:35 PM CST
Polaris Group Market Cap
Polaris Group has a market cap or net worth of 23.88 billion as of January 30, 2026. Its market cap has decreased by -32.19% in one year.
Market Cap
23.88B
Enterprise Value
26.24B
Revenue
70.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
30.65
Market Cap Chart
Since February 15, 2016, Polaris Group's market cap has decreased from 46.46B to 23.88B, a decrease of -48.59%. That is a compound annual growth rate of -6.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 23.88B | -0.32% |
| Dec 31, 2025 | 23.96B | -29.66% |
| Dec 31, 2024 | 34.06B | -39.39% |
| Dec 29, 2023 | 56.21B | -14.57% |
| Dec 30, 2022 | 65.79B | 24.20% |
| Dec 30, 2021 | 52.97B | 373.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pell Bio-Med Technology | 38.74B |
| Lin BioScience | 31.68B |
| Oneness Biotech | 31.48B |
| Lumosa Therapeutics | 29.57B |
| Sunmax Biotechnology | 21.10B |
| EirGenix | 18.82B |
| TaiMed Biologics | 15.46B |
| AP Biosciences | 14.68B |